Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$53.02
0.681.30%
At close: -
$53.02
0.000.00%
After Hours: Jun 20, 4:00 PM EDT
Comments
Loading...
Exact Sciences Analyst Ratings and Price Targets | NASDAQ:EXAS | Benzinga
Exact Sciences Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Exact Sciences Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
RBC Capital
Evercore ISI Group
Baird
Guggenheim
1calculated from analyst ratings
Analyst Ratings for Exact Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/02/2025 | Buy Now | — | Barclays | Luke Sergott51% | $55 → $75 | Maintains | Overweight | Get Alert |
| 05/02/2025 | Buy Now | — | RBC Capital | Gerard Cassidy73% | $52 → $54 | Maintains | Sector Perform | Get Alert |
| 05/02/2025 | Buy Now | — | Evercore ISI Group | Vijay Kumar50% | $60 → $66 | Maintains | Outperform | Get Alert |
| 05/02/2025 | Buy Now | — | Baird | Catherine Schulte66% | $69 → $72 | Maintains | Outperform | Get Alert |
| 04/11/2025 | Buy Now | — | Guggenheim | Subbu Nambi49% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
| 04/10/2025 | Buy Now | — | Barclays | Luke Sergott51% | $65 → $55 | Maintains | Overweight | Get Alert |
| 04/10/2025 | Buy Now | — | Mizuho | Anthony Petrone64% | → $60 | Initiates | → Outperform | Get Alert |
| 03/13/2025 | Buy Now | — | RBC Capital | Gerard Cassidy73% | → $52 | Initiates | → Sector Perform | Get Alert |
| 02/26/2025 | Buy Now | — | Piper Sandler | David Westenberg61% | $75 → $70 | Maintains | Overweight | Get Alert |
| 02/24/2025 | Buy Now | — | Scotiabank | Sung Ji Nam47% | $70 → $73 | Maintains | Sector Outperform | Get Alert |
| 02/20/2025 | Buy Now | — | B of A Securities | Derik De Bruin84% | $72 → $65 | Maintains | Buy | Get Alert |
| 02/20/2025 | Buy Now | — | Barclays | Luke Sergott51% | $70 → $65 | Maintains | Overweight | Get Alert |
| 01/23/2025 | Buy Now | — | Barclays | Luke Sergott51% | → $70 | Initiates | → Overweight | Get Alert |
| 01/13/2025 | Buy Now | — | Benchmark | Bruce Jackson40% | $65 → $65 | Reiterates | Buy → Buy | Get Alert |
| 12/13/2024 | Buy Now | — | B of A Securities | Derik De Bruin84% | $75 → $72 | Maintains | Buy | Get Alert |
| 11/26/2024 | Buy Now | — | TD Cowen | Dan Brennan63% | $82 → $86 | Maintains | Buy | Get Alert |
| 11/26/2024 | Buy Now | — | BTIG | Mark Massaro71% | $65 → $75 | Maintains | Buy | Get Alert |
| 11/11/2024 | Buy Now | — | Piper Sandler | David Westenberg61% | $85 → $75 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | — | Citigroup | Patrick Donnelly80% | $80 → $75 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | — | Jefferies | Brandon Couillard69% | $84 → $85 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | — | BTIG | Mark Massaro71% | $82 → $65 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | — | Stifel | Daniel Arias78% | $82 → $67 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | — | Canaccord Genuity | Kyle Mikson41% | $95 → $75 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | — | TD Cowen | Dan Brennan63% | $90 → $82 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | — | Goldman Sachs | Matthew Sykes64% | $75 → $65 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | — | Evercore ISI Group | Vijay Kumar50% | $80 → $60 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | — | Craig-Hallum | Alex Nowark61% | $82 → $65 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | — | Benchmark | Bruce Jackson40% | $67 → $65 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | — | Baird | Catherine Schulte66% | $70 → $67 | Maintains | Outperform | Get Alert |
| 10/30/2024 | Buy Now | — | Bernstein | Eve Burstein45% | $75 → $90 | Maintains | Outperform | Get Alert |
| 10/29/2024 | Buy Now | — | Canaccord Genuity | Kyle Mikson41% | $75 → $95 | Maintains | Buy | Get Alert |
| 10/01/2024 | Buy Now | — | Evercore ISI Group | Vijay Kumar50% | $72 → $80 | Maintains | Outperform | Get Alert |
| 09/26/2024 | Buy Now | — | Raymond James | Andrew Cooper54% | — | Reiterates | → Market Perform | Get Alert |
| 09/13/2024 | Buy Now | — | Canaccord Genuity | Kyle Mikson41% | $75 → $75 | Maintains | Buy | Get Alert |
| 09/12/2024 | Buy Now | — | Piper Sandler | David Westenberg61% | $75 → $85 | Maintains | Overweight | Get Alert |
| 08/27/2024 | Buy Now | — | Wells Fargo | Brandon Couillard69% | → $75 | Initiates | → Overweight | Get Alert |
| 08/01/2024 | Buy Now | — | Benchmark | Bruce Jackson40% | $91 → $67 | Maintains | Buy | Get Alert |
| 08/01/2024 | Buy Now | — | Stifel | Daniel Arias78% | $100 → $82 | Maintains | Buy | Get Alert |
| 07/17/2024 | Buy Now | — | Goldman Sachs | Matthew Sykes64% | $88 → $75 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | — | Evercore ISI Group | Vijay Kumar50% | $80 → $72 | Maintains | Outperform | Get Alert |
| 06/27/2024 | Buy Now | — | BTIG | Mark Massaro71% | $80 → $70 | Maintains | Buy | Get Alert |
| 06/27/2024 | Buy Now | — | Scotiabank | Sung Ji Nam47% | → $70 | Initiates | → Sector Outperform | Get Alert |
| 06/26/2024 | Buy Now | — | BTIG | Mark Massaro71% | $80 → $70 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | — | BTIG | Mark Massaro71% | $85 → $80 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | — | Canaccord Genuity | Kyle Mikson41% | $90 → $85 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | — | Citigroup | Patrick Donnelly80% | $100 → $80 | Maintains | Buy | Get Alert |
| 04/03/2024 | Buy Now | — | Citigroup | Patrick Donnelly80% | → $100 | Maintains | Buy | Get Alert |
| 02/22/2024 | Buy Now | — | Canaccord Genuity | Kyle Mikson41% | $100 → $90 | Maintains | Buy | Get Alert |
| 01/02/2024 | Buy Now | — | Benchmark | Bruce Jackson40% | → $91 | Upgrade | Hold → Buy | Get Alert |
| 12/14/2023 | Buy Now | — | Guggenheim | Subbu Nambi49% | → $90 | Initiates | → Buy | Get Alert |
| 12/13/2023 | Buy Now | — | Wolfe Research | Doug Schenkel72% | — | Initiates | → Outperform | Get Alert |
| 11/03/2023 | Buy Now | — | Goldman Sachs | Matthew Sykes64% | $100 → $90 | Maintains | Buy | Get Alert |
| 10/16/2023 | Buy Now | — | Piper Sandler | David Westenberg61% | $90 → $80 | Maintains | Overweight | Get Alert |
| 10/10/2023 | Buy Now | — | Piper Sandler | David Westenberg61% | → $90 | Upgrade | Neutral → Overweight | Get Alert |
| 09/28/2023 | Buy Now | — | Bernstein | Eve Burstein45% | → $83 | Initiates | → Outperform | Get Alert |
| 08/08/2023 | Buy Now | — | Piper Sandler | David Westenberg61% | $80 → $90 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | — | Jefferies | Brandon Couillard69% | $100 → $110 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | — | Credit Suisse | Dan Leonard55% | $75 → $90 | Maintains | Neutral | Get Alert |
| 08/02/2023 | Buy Now | — | Baird | Catherine Schulte66% | $99 → $121 | Maintains | Outperform | Get Alert |
| 08/02/2023 | Buy Now | — | Benchmark | Bruce Jackson40% | — | Downgrade | Buy → Hold | Get Alert |
| 07/24/2023 | Buy Now | — | Goldman Sachs | Matthew Sykes64% | $85 → $110 | Maintains | Buy | Get Alert |
| 07/21/2023 | Buy Now | — | Goldman Sachs | Matthew Sykes64% | $85 → $110 | Maintains | Buy | Get Alert |
| 06/23/2023 | Buy Now | — | Canaccord Genuity | Kyle Mikson41% | $92 → $115 | Maintains | Buy | Get Alert |
| 06/22/2023 | Buy Now | — | Citigroup | Patrick Donnelly80% | $100 → $130 | Maintains | Buy | Get Alert |
| 06/22/2023 | Buy Now | — | Benchmark | Bruce Jackson40% | → $96 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2023 | Buy Now | — | Stifel | Daniel Arias78% | → $85 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2023 | Buy Now | — | Canaccord Genuity | Kyle Mikson41% | → $92 | Reiterates | Buy → Buy | Get Alert |
| 06/07/2023 | Buy Now | — | Jefferies | Brandon Couillard69% | $82 → $100 | Maintains | Buy | Get Alert |
| 05/11/2023 | Buy Now | — | Citigroup | Patrick Donnelly80% | $90 → $100 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | — | Jefferies | Brandon Couillard69% | $72 → $82 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | — | B of A Securities | Derik De Bruin84% | $80 → $88 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | — | Credit Suisse | Dan Leonard55% | $70 → $75 | Maintains | Neutral | Get Alert |
| 05/10/2023 | Buy Now | — | Baird | Catherine Schulte66% | $92 → $99 | Maintains | Outperform | Get Alert |
| 05/10/2023 | Buy Now | — | Craig-Hallum | Alex Nowark61% | $55 → $85 | Upgrade | Hold → Buy | Get Alert |
| 05/05/2023 | Buy Now | — | UBS | Elizabeth Garcia72% | → $73 | Initiates | → Neutral | Get Alert |
| 03/15/2023 | Buy Now | — | Benchmark | Bruce Jackson40% | $54 → $78 | Maintains | Buy | Get Alert |
| 03/09/2023 | Buy Now | — | Citigroup | Patrick Donnelly80% | $70 → $90 | Upgrade | Neutral → Buy | Get Alert |
| 03/03/2023 | Buy Now | — | Piper Sandler | David Westenberg61% | $50 → $70 | Maintains | Neutral | Get Alert |
| 02/22/2023 | Buy Now | — | Cowen & Co. | Dan Brennan63% | $56 → $76 | Maintains | Outperform | Get Alert |
| 02/22/2023 | Buy Now | — | Baird | Catherine Schulte66% | $89 → $92 | Maintains | Outperform | Get Alert |
| 02/22/2023 | Buy Now | — | BTIG | Mark Massaro71% | $85 → $80 | Maintains | Buy | Get Alert |
| 02/22/2023 | Buy Now | — | Canaccord Genuity | Kyle Mikson41% | $70 → $75 | Maintains | Buy | Get Alert |
| 02/22/2023 | Buy Now | — | Citigroup | Patrick Donnelly80% | $35 → $70 | Maintains | Neutral | Get Alert |
| 02/22/2023 | Buy Now | — | Credit Suisse | Dan Leonard55% | → $70 | Reiterates | → Neutral | Get Alert |
| 02/10/2023 | Buy Now | — | Credit Suisse | Dan Leonard55% | $50 → $70 | Downgrade | Outperform → Neutral | Get Alert |
| 01/18/2023 | Buy Now | — | Raymond James | Andrew Cooper54% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/12/2023 | Buy Now | — | SVB Leerink | Puneet Souda56% | $70 → $75 | Maintains | Outperform | Get Alert |
| 01/06/2023 | Buy Now | — | SVB Leerink | Puneet Souda56% | $60 → $70 | Maintains | Outperform | Get Alert |
| 12/16/2022 | Buy Now | — | Jefferies | Brandon Couillard69% | → $70 | Maintains | Buy | Get Alert |
| 11/14/2022 | Buy Now | — | Piper Sandler | David Westenberg61% | $40 → $50 | Maintains | Neutral | Get Alert |
| 11/08/2022 | Buy Now | — | Raymond James | Andrew Cooper54% | $70 → $60 | Maintains | Outperform | Get Alert |
| 11/07/2022 | Buy Now | — | BTIG | Mark Massaro71% | $70 → $65 | Maintains | Buy | Get Alert |
| 10/19/2022 | Buy Now | — | Craig-Hallum | Alexander Nowak53% | — | Downgrade | Buy → Hold | Get Alert |
| 08/25/2022 | Buy Now | — | Credit Suisse | Dan Leonard55% | → $55 | Initiates | → Outperform | Get Alert |
| 08/17/2022 | Buy Now | — | Piper Sandler | David Westenberg61% | $50 → $40 | Maintains | Overweight | Get Alert |
| 08/03/2022 | Buy Now | — | Craig-Hallum | Alex Nowark61% | $81 → $60 | Maintains | Buy | Get Alert |
| 08/03/2022 | Buy Now | — | Cowen & Co. | Dan Brennan63% | $83 → $67 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | — | BTIG | Mark Massaro71% | $100 → $70 | Maintains | Buy | Get Alert |
| 08/03/2022 | Buy Now | — | Baird | Catherine Ramsey55% | $90 → $75 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | — | Citigroup | Patrick Donnelly80% | $65 → $50 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Exact Sciences (EXAS) stock?
The latest price target for Exact Sciences (NASDAQ:EXAS) was reported by Barclays on May 2, 2025. The analyst firm set a price target for $75.00 expecting EXAS to rise to within 12 months (a possible 41.46% upside). 43 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Exact Sciences (EXAS)?
The latest analyst rating for Exact Sciences (NASDAQ:EXAS) was provided by Barclays, and Exact Sciences maintained their overweight rating.
When was the last upgrade for Exact Sciences (EXAS)?
The last upgrade for Exact Sciences Corp happened on January 2, 2024 when Benchmark raised their price target to $91. Benchmark previously had a hold for Exact Sciences Corp.
When was the last downgrade for Exact Sciences (EXAS)?
The last downgrade for Exact Sciences Corp happened on August 2, 2023 when Benchmark changed their price target from N/A to N/A for Exact Sciences Corp.
When is the next analyst rating going to be posted or updated for Exact Sciences (EXAS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exact Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exact Sciences was filed on May 2, 2025 so you should expect the next rating to be made available sometime around May 2, 2026.
Is the Analyst Rating Exact Sciences (EXAS) correct?
While ratings are subjective and will change, the latest Exact Sciences (EXAS) rating was a maintained with a price target of $55.00 to $75.00. The current price Exact Sciences (EXAS) is trading at is $53.02, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
